CymitQuimica logo

CAS 163250-91-7

:

Orbofiban acetate

Description:
Orbofiban acetate is a synthetic compound that belongs to the class of antiplatelet agents, specifically designed to inhibit platelet aggregation. It functions as a selective antagonist of the glycoprotein IIb/IIIa receptor, which plays a crucial role in the final common pathway of platelet activation and aggregation. This mechanism makes Orbofiban acetate potentially useful in preventing thrombotic events in various cardiovascular conditions. The compound is typically administered in a pharmaceutical formulation, and its acetate form enhances solubility and bioavailability. Orbofiban acetate has been studied for its efficacy in clinical settings, particularly in patients undergoing percutaneous coronary interventions or those at high risk for thrombotic complications. Its pharmacokinetic profile includes considerations of absorption, distribution, metabolism, and excretion, which are essential for determining dosing regimens. As with many antiplatelet agents, potential side effects may include bleeding complications, necessitating careful monitoring during treatment. Overall, Orbofiban acetate represents a significant advancement in the management of cardiovascular diseases related to platelet function.
Formula:C17H23N5O4·C2H4O2
InChI:InChI=1S/C17H23N5O4.C2H4O2/c1-2-26-14(23)7-9-20-17(25)21-13-8-10-22(16(13)24)12-5-3-11(4-6-12)15(18)19;1-2(3)4/h3-6,13H,2,7-10H2,1H3,(H3,18,19)(H2,20,21,25);1H3,(H,3,4)/t13-;/m0./s1
InChI key:InChIKey=PKHRWVBUJHJCLV-ZOWNYOTGSA-N
SMILES:O=C1N(CC[C@@H]1NC(NCCC(OCC)=O)=O)C2=CC=C(C(=N)N)C=C2.C(C)(O)=O
Synonyms:
  • SC 57099B
  • β-Alanine, N-[[[(3S)-1-[4-(aminoiminomethyl)phenyl]-2-oxo-3-pyrrolidinyl]amino]carbonyl]-, ethyl ester, monoacetate
  • Orbofiban acetate
  • β-Alanine, N-[[[1-[4-(aminoiminomethyl)phenyl]-2-oxo-3-pyrrolidinyl]amino]carbonyl]-, ethyl ester, (S)-, monoacetate
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.